Scilex Holding Co. (SCLX)
5.04
-0.33
(-6.15%)
USD |
NASDAQ |
Sep 18, 16:00
5.09
+0.05
(+0.99%)
After-Hours: 20:00
Scilex Cash from Operations (Quarterly) : -6.723M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.723M |
| March 31, 2026 | -1.107M |
| December 31, 2025 | -17.88M |
| September 30, 2025 | 8.437M |
| June 30, 2025 | 7.281M |
| March 31, 2025 | 6.007M |
| December 31, 2024 | 2.366M |
| September 30, 2024 | 5.396M |
| June 30, 2024 | 2.257M |
| March 31, 2024 | 9.391M |
| December 31, 2023 | -5.378M |
| Date | Value |
|---|---|
| September 30, 2023 | 5.950M |
| June 30, 2023 | -13.42M |
| March 31, 2023 | -7.744M |
| December 31, 2022 | -19.21M |
| September 30, 2022 | 2.644M |
| June 30, 2022 | -12.13M |
| March 31, 2022 | -10.73M |
| December 31, 2021 | -27.70M |
| September 30, 2021 | -0.1348M |
| June 30, 2021 | -0.0574M |
| March 31, 2021 | -0.4943M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | -0.2799M |
| Semnur Pharmaceuticals, Inc. | -2.138M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 8.452M |
| Cash from Financing (Quarterly) | -4.491M |
| Free Cash Flow | -61.82M |
| Free Cash Flow Per Share (Quarterly) | -1.832 |
| Free Cash Flow to Equity (Quarterly) | -12.25M |
| Free Cash Flow to Firm (Quarterly) | -6.521M |
| Free Cash Flow Yield | -151.3% |